1. Yeates KE, Singer M, Morton AR. Salt and water: a simple approach to hyponatremia. CMAJ. 2004; 170:365–369.
2. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000; 342:1581–1589.
3. Torales J, Halperin I, Hanzu F, Mora M, Alobid I, De Notaris M, et al. Endoscopic endonasal surgery for pituitary tumors: results in a series of 121 patients operated at the same center and by the same neurosurgeon. Endocrinol Nutr. 2014; 61:410–416.
4. Taylor SL, Tyrrell JB, Wilson CB. Delayed onset of hyponatremia after transsphenoidal surgery for pituitary adenomas. Neurosurgery. 1995; 37:649–653.
5. Cooper BC, Murray CA. Syndrome of inappropriate antidiuretic hormone in a healthy woman after diagnostic laparoscopy and hysteroscopy: a case report. J Reprod Med. 2006; 51:199–201.
6. Chung HM, Kluge R, Schrier RW, Anderson RJ. Postoperative hyponatremia: a prospective study. Arch Intern Med. 1986; 146:333–336.
7. Fieldman NR, Forsling ML, Le Quesne LP. The effect of vasopressin on solute and water excretion during and after surgical operations. Ann Surg. 1985; 201:383–390.
8. Anderson RJ. Hospital-associated hyponatremia. Kidney Int. 1986; 29:1237–1247.
9. Hanagiri T, Muranaka H, Hashimoto M, Nagashima A. A syndrome of inappropriate secretion of antidiuretic hormone associated with pleuritis caused by OK-432. Respiration. 1998; 65:310–312.
10. Ghali JK, Hamad B, Yasothan U, Kirkpatrick P. Tolvaptan. Nat Rev Drug Discov. 2009; 8:611–612.
11. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006; 355:2099–2112.